PAHC
PHIBRO ANIMAL HEALTH CORP
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$39.34
+1.34%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$39.23
From 52W high−33.97%
Volume184836.00
Market cap$1.60B
P/E (TTM)16.0x
P/S (TTM)1.1x
Div yield1.22%
Key dataOct 19, 2026
Open
$39.23
From 52W high
−33.97%
Volume
184836.00
Market cap
$1.60B
ValuationView details →
P/E (Fwd)
11.1x
EV/EBITDA
9.7x
P/E (TTM)
16.0x
RSI (14)
66.0
MomentumView details →
1D Return
+1.34%
YTD Return
+5.91%
SummaryUpdated Jun 1, 2026
Phibro Animal Health Corporation (NASDAQ:PAHC) is a specialty animal health company that develops, manufactures, and markets products for livestock and companion animals. Founded as Philipp Brothers Chemicals in the early 20th century, the company changed its name to Phibro Animal Health Corporation in 2003 and went public in 2014. Headquartered in Teaneck, New Jersey, Phibro operates globally with manufacturing facilities in the United States, Brazil, and Ireland, serving customers across North America, Latin America, Europe, Asia Pacific, and other international markets.
Similar companies
Latest newsMore news →
Phibro Animal Health Corporation reported financial results for the fourth quarter and fiscal year ended June 30, 2026, with net sales of $396.7 million and net income of $21.7 million for the quarter, and provided financial guidance for fiscal year 2027.54d agoPhibro Animal Health Corporation's board declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock, payable on September 23, 2026, to stockholders of record on September 2, 2026.83d ago